Article
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.
Clinical and molecular hepatology - 1 Sept 2013
Yim Hyung Joon, Hwang Seong Gyu
Abstract excerpt
Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a number of patients, and it is still being used especially in resource limited countries. Once antiviral resistance occurs, it predisposes to subsequent resistance, resulting in multidrug resistance....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
